Observational studyThe Korean journal of internal medicine2016

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.

Jang Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.